NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for etoposide


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Data from Meiji University provide new insights into apoptosis
2009 NOV 10 ... for ATG2A, ATG9B, and WIPI2. In particular, ATG2A was the only upregulated gene in the etoposide-induced apoptosis of HeLa cells. ATG2A mRNA was also upregulated by doxorubicin. ...
Subject: Apoptosis
Price: $3.00
*
Findings from University of Louisiana in natural products reported
2009 NOV 17 ... out of 14 betulinic acid analogues (5, 9, 11, and 12) showed 1.5-fold the activity of etoposide in a topoisomerase II assay. The new analogues exhibited better cytotoxic activities ...
Subject: Natural Products
Price: $3.00
*
Investigators at University of Granada target chromosomal abnormalities
2009 NOV 2 ... arise in utero. They can be induced during human prenatal development upon exposure to etoposide," scientists in Granada, Spain report. "We also hypothesize that chronic ...
Subject: Chromosomal Abnormalities
Price: $3.00
*
New cancer therapy research reported from National Cancer Center Hospital, Department of Medical Oncology
2009 NOV 16 ... vincristine (1 mg m(-2)) on weeks 1, 2, 4, 6 and 8; and doxorubicin (40 mg m(-2)) and etoposide (80 mg m(-2)) on days 1-3 of weeks 1, 3, 5, 7 and 9. Chemotherapy courses were supported ...
Subject: Cancer Therapy
Price: $3.00
*
New findings from Toranomon Hospital, Department of Haematology describe advances in cord blood
2009 NOV 16 ... interventions including corticosteroid, ciclosporin, high-dose immunoglobulin and/or etoposide, engraftment failed in 14 of 18 patients. Of these 14 patients, four received second ...
Subject: Cord Blood
Price: $3.00
*
New neuroendocrine cancer research has been reported by scientists at Uppsala University, Medical Department
2009 NOV 2 ... bronchial carcinoid cell line NCI-H720 were used. Combinations between doxorubicin, etoposide, oxaliplatin, docetaxel, and each one of the five agents were studied and simultaneous ...
Subject: Neuroendocrine Cancer
Price: $3.00
*
New retinoblastoma study findings recently were reported by R. Cozza and co-researchers
2009 NOV 2 ... and radiotherapy with or without high-dose chemotherapy. An ifosfamide/carboplatin/etoposide regimen was administered in three patients resulting in a partial response. Out of six ...
Subject: Retinoblastoma
Price: $3.00
*
Recent studies from University of Pavia add new data to life sciences in children
2009 NOV 2 ... Current study results from the report, 'Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed ...
Subject: Life Sciences
Price: $3.00
*
Report summarizes cancer study findings from University of Copenhagen
2009 NOV 23 ... of apoptosis." "Other chemotherapeutic inducers of apoptosis such as etoposide and camptothecin also led to a robust induction of Hsp70 surface expression. Hsp70 ...
Subject: Cancer
Price: $3.00
*
Research on genetics published by scientists at Westfalische Wilhelms University Munster, Institute for Biochemistry
2009 NOV 9 ... cells show an increased sensitivity to agents that cause DNA damage, such as UV light, etoposide or ethyl-methanesulfonate. In summary, our findings show that Pdcd4 has an important ...
Subject: Genetics
Price: $3.00
*
Research on ovarian cancer described by H. Kang and colleagues
2009 NOV 16 ... this trial was to investigate the efficacy and toxicity of combination chemotherapy with etoposide and ifosfamide (ETI) in the management of heavily pretreated recurrent or persistent ...
Subject: Ovarian Cancer
Price: $3.00
*
Research reports from University of Pittsburgh provide new insights into myeloid leukemia therapy
2009 NOV 23 ... Research findings, 'Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a ...
Subject: Myeloid Leukemia Therapy
Price: $3.00
*
Research reports on apoptosis from University of Texas provide new insights
2009 NOV 2 ... this oxidative stress. Combining ABT-737 with ROS-inducing agents such as adaphostin or etoposide enhanced cell death. These results demonstrate that inhibition of Bcl-2 causes a loss of ...
Subject: Apoptosis
Price: $3.00
*
Researchers from Shanghai Jiaotong University detail findings in cancer gene therapy
2009 NOV 2 ... tumor-killing ability either alone or in combination with the chemotherapeutic agent etoposide. Our data show that low-dose CRAd facilitated the replication of replication-deficient ...
Subject: Cancer Gene Therapy
Price: $3.00
*
Researchers from University of Hamburg, Department of Chemistry report recent findings in DNA research
2009 NOV 23 ... lower than mammalian enzymes, the preferred targets of anticancer drugs such as etoposide." "The mechanisms of action of both of these types of inhibitors involve ...
Subject: DNA Research
Price: $3.00
*
Scientists at Erasmus University, Daniel den Hoed Cancer Center describe research in cancer therapy
2009 NOV 2 ... metastatic germ-cell cancer have an excellent prognosis. Since the 1980s, bleomycin, etoposide and cisplatin (BEP) have become the standard chemotherapy regimen for these patients," ...
Subject: Cancer Therapy
Price: $3.00
*
Scientists at National Taiwan University release new data on hepatocellular cancer
2009 NOV 16 ... several designs were used to investigate the resistance mechanism to camptothecin and etoposide in hepatocellular carcinoma Hep3B cells. Tunicamycin significantly inhibited apoptosis ...
Subject: Hepatocellular Cancer
Price: $3.00
*
Study findings from University of Athens broaden understanding of life sciences
2009 NOV 9 ... weeks of gestation. She received four postoperative courses of chemotherapy (cisplatin, etoposide, and peplomycin). Currently, mother and child are doing well 6 months after the last ...
Subject: Life Sciences
Price: $3.00
*
Study results from University of California in the area of chemotherapy published
2009 NOV 2 ... consolidation chemotherapy using cytarabine 2000 mg/m(2) i.v. every 12 h for 4 days plus etoposide 40 mg/kg total dose by continuous i.v. infusion over the same 4 days," scientists ...
Subject: Chemotherapy
Price: $3.00
*
Study results from University of North Carolina provide new insights into small cell lung cancer
2009 NOV 9 ... trial in which pemetrexed-platinum demonstrated similar activity to that of historical etoposide-platinum controls, a phase III study was conducted to compare pemetrexed-carboplatin ...
Subject: Small Cell Lung Cancer
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login